New Molecules Committee gives a favorable opinion to the Cuban Sovereign vaccine

The Cuban Vaccine sovereign once morest COVID-19, received a favorable opinion from the New Molecules Committee (CMN) de la Federal Commission for the Protection once morest Sanitary Risks (Cofepris).

Sovereign Vaccine ???? receives a favorable technical opinion from the New Molecules Committee.

It is the second Latin American vaccine to be submitted for consideration by the Committee. The result represents a step prior to authorization for emergency use.https://t.co/QfCcoi8Uw2 pic.twitter.com/h2vgiCXv9T

— COFEPRIS (@COFEPRIS) September 10, 2022

Through a statement, the Cofepris He explained that during the 165th Special Session the technical-scientific information for the evaluation of the vaccine was presented. sovereign for adults, receiving a favorable technical opinion.

It’s regarding the second Latin American vaccine to submit to the consideration of the CMN followed by Ratherfirst biological Spanish American once morest COVID-19, presented on August 31, 2021.

“The evidence was presented for the use of the Soberana vaccine as primary vaccination in adults, that is, for the population that has not been previously immunized. This product consists of a protein conjugate of recombinant SARS-CoV-2 protein S receptor binding domain (RBD) with tetanus toxoid, with aluminum hydroxide as adjuvant”, indicated Cofepris.

The agency also highlighted that this result represents a previous step to the emergency use authorization.

With information from López-Dóriga Digital